Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lenenergo reported for 2023 by RAS

3/19/24 LSNG

Cherkizovo Group in 2023 increased chicken sales by 18.1%

3/19/24 GCHE

Rosseti South reported for 2023 by RAS accounting standards

3/18/24 MRKY

Novoship reported for 2023 by RAS

3/18/24 NOMP

Metacraft - like Minecraft, only better

3/18/24 OTCI

Founder of LSR Andrey Molchanov reduced his stake in the company

3/18/24 LSRG

Rosseti Moscow Region reported for 2023 by RAS

3/18/24 MSRS

Rosseti Moscow Region reported for 2023 by IFRS

3/18/24 MSRS

Mosgorlombard starts conversion of preferred shares

3/18/24 MGKL

NKHP reported for 2023 by RAS

3/18/24 NKHP